These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 20865470)

  • 1. Infectious complications in neutropenic cancer patients.
    Menichetti F
    Intern Emerg Med; 2010 Oct; 5 Suppl 1():S21-5. PubMed ID: 20865470
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A European Organization for Research and Treatment of Cancer-International Antimicrobial Therapy Group Study of secondary infections in febrile, neutropenic patients with cancer.
    Akova M; Paesmans M; Calandra T; Viscoli C;
    Clin Infect Dis; 2005 Jan; 40(2):239-45. PubMed ID: 15655741
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Fever in the neutropenic patient].
    Milpied N
    Rev Prat; 2001 Mar; 51(6):633-7. PubMed ID: 11345865
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Secondary Infections in Febrile Neutropenia in Hematological Malignancies: More Than Another Febrile Neutropenic Episode.
    Demirel A; Tabak F; Ar MC; Mete B; Öngören Ş; Yemişen M; Özaras R; Eşkazan E; Başlar Z; Mert A; Soysal T; Ferhanoğlu B; Aydın Y; Öztürk R
    Turk J Haematol; 2015 Sep; 32(3):243-50. PubMed ID: 25913035
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Infectious complications in neutropenic patients with malignant hemopathies. A prospective study of 279 cases of neutropenia].
    Berenguer J; Díaz Mediavilla J; Martínez R; Fernández A; del Potro E; Muñoz P
    Med Clin (Barc); 1990 Oct; 95(13):481-5. PubMed ID: 2084424
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Importance of neutropenia for development of invasive infections at various phases of treatment for hemato-oncological diseases in children.
    Zwitserloot AM; Mavinkurve-Groothuis AM; Galama JM; Verweij PE; Hoogerbrugge PM; Warris A
    Scand J Infect Dis; 2012 May; 44(5):355-62. PubMed ID: 22216875
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Application of the concepts of evidence-based medicine to the evidence on the treatment of febrile neutropenia].
    Jarque I; Sanz MA
    Enferm Infecc Microbiol Clin; 1999; 17 Suppl 2():95-102. PubMed ID: 10605194
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Febrile neutropenia in the tropics: a description of clinical and microbiological findings and their impact on inappropriate therapy currently used at an oncological reference center in Colombia.
    Cortés JA; Cuervo S; Gómez CA; Bermúdez D; Martínez T; Arroyo P
    Biomedica; 2013; 33(1):70-7. PubMed ID: 23715309
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibiotic prophylaxis in neutropenic children with acute leukemia: Do the presently available data really support this practice?
    Calitri C; Ruberto E; Castagnola E
    Eur J Haematol; 2018 Dec; 101(6):721-727. PubMed ID: 30107054
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reducing infectious complications after allogeneic stem cell transplant.
    Bacigalupo A; Metafuni E; Amato V; Marquez Algaba E; Pagano L
    Expert Rev Hematol; 2020 Nov; 13(11):1235-1251. PubMed ID: 32996342
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Infections in neutropenic patients I: aetiology.
    Engervall P; Björkholm M
    Med Oncol; 1995 Dec; 12(4):251-6. PubMed ID: 8832528
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A prospective study on the epidemiology of febrile episodes during chemotherapy-induced neutropenia in children with cancer or after hemopoietic stem cell transplantation.
    Castagnola E; Fontana V; Caviglia I; Caruso S; Faraci M; Fioredda F; Garrè ML; Moroni C; Conte M; Losurdo G; Scuderi F; Bandettini R; Tomà P; Viscoli C; Haupt R
    Clin Infect Dis; 2007 Nov; 45(10):1296-304. PubMed ID: 17968824
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A proposed score for predicting severe infection complications in children with chemotherapy-induced febrile neutropenia.
    Rondinelli PI; Ribeiro Kde C; de Camargo B
    J Pediatr Hematol Oncol; 2006 Oct; 28(10):665-70. PubMed ID: 17023827
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Treatment and prevention of infections in cancer patients with neutropenia].
    Sinkó J
    Magy Onkol; 2011 Sep; 55(3):155-63. PubMed ID: 21918740
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incidence and risk factors of bacterial and fungal infection during induction chemotherapy for high-risk neuroblastoma.
    Whittle SB; Williamson KC; Russell HV
    Pediatr Hematol Oncol; 2017 Aug; 34(5):331-342. PubMed ID: 29200325
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Treatment of symptoms in the course of neutropenia].
    Wróbel T; Mazur G; Kaczmarek P
    Pol Arch Med Wewn; 1999 Mar; 101(3):251-7. PubMed ID: 10697404
    [No Abstract]   [Full Text] [Related]  

  • 17. Cefpodoxime for antimicrobial prophylaxis in neutropenia: a retrospective case series.
    Wojenski DJ; Barreto JN; Wolf RC; Tosh PK
    Clin Ther; 2014 Jun; 36(6):976-81. PubMed ID: 24832560
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neutropenia in patients with HIV infection: a case control study in a cohort of 1403 patients between 1982 and 1993.
    Hermans P; Sommereijns B; Van Cutsem N; Clumeck N
    J Hematother Stem Cell Res; 1999; 8 Suppl 1():S23-32. PubMed ID: 10596033
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evolving risk factors for invasive fungal infections--all neutropenic patients are not the same.
    Walsh TJ; Hiemenz J; Pizzo PA
    Clin Infect Dis; 1994 May; 18(5):793-8. PubMed ID: 8075273
    [No Abstract]   [Full Text] [Related]  

  • 20. [Infection and cancer: general information and specific questions].
    Viot M; Blanc-Vincent MP; Béal J; Biron P; Boutard P; Malgrange VB; Crokaert F; Escande MC; Fuhrmann C; Lesimple T; Pény J; Pottecher B; Raveneau J; Senet JM; Thyss A
    Presse Med; 2000 Oct; 29(29):1630-3. PubMed ID: 11072368
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.